Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Thermo Fisher Scientific Inc.. (4/4/16). "Press Release: Thermo Fisher Scientific Prices Offering of Senior Notes". Waltham, MA.

Organisations Organisation Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
  Organisation 2 Merrill Lynch, Pierce, Fenner & Smith Inc.
  Group Bank of America (BofA) (Group)
Products Product investment banking
  Product 2 laboratory equipment and instruments
Index term Index term Thermo Fisher–SEVERAL: credit, 201604 sale $1b 3% Senior Notes due 2023
Persons Person O’Brien, Ron (Thermo Fisher 201003 Director Public Relations)
  Person 2 Apicerno, Ken (Thermo Fisher 201003 Investor Relations)
     


Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has priced an offering of $1.0 billion aggregate principal amount of 3.000% senior notes due 2023 at an issue price of 99.512% of the principal amount.

The issuance of the notes is expected to close on or about April 13, 2016, subject to customary closing conditions. The notes will pay interest on a semi-annual basis.

Thermo Fisher plans to use the net proceeds of the offering and cash on hand to redeem all of the outstanding $1.0 billion aggregate principal amount of its 2.250% senior notes that mature on August 15, 2016.

The joint book-running managers for the offering are Merrill Lynch, Pierce, Fenner & Smith Incorporated; Goldman, Sachs & Co. and Morgan Stanley & Co. LLC.

The offering will be made pursuant to an effective registration statement on Form S-3 (including a prospectus) filed with the Securities and Exchange Commission (the “SEC”). Prospective investors should read the prospectus forming a part of that registration statement and the prospectus supplement related to the offering and the other documents that the company has filed with the SEC for more complete information about the company and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Thermo Fisher, the underwriters or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at 1-800-294-1322; by calling Goldman, Sachs & Co toll-free at 1-866-471-2526; or by calling Morgan Stanley & Co. LLC toll-free at 1-866-718-1649.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes, nor shall there be any offer, solicitation or sale of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.


Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about the company’s intended use of proceeds. These statements involve a number of risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including risks and uncertainties relating to capital markets conditions and completion of the offering. Additional important factors and information regarding Thermo Fisher’s business that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the prospectus and prospectus supplement dated April 4, 2016 related to the offering, which is on file with the SEC and available in the “Investors” section of our website under the heading “SEC Filings,” and the documents incorporated by reference into the prospectus and prospectus supplement. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if circumstances change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.


Contact:

Thermo Fisher Scientific Inc.

Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com

or

Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

   
Record changed: 2016-04-10

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px